Pharmaceutical Industry Information Portal

HomeNews

News

Avifavir® for the treatment of COVID-19 is rated among Russia’s TOP 100 Inventions

Avifavir® became the world’s first approved favipiravir-based drug for COVID-19 infection treatment and the first drug against COVID-19 authorized in Russia.

Production of Sputnik V abroad will be up to 6 mln doses a month from July

Via the Russian Direct Investment Fund, the authorities established a mechanism for using foreign sites, where the substance for the production of vaccines is sent to, the minister said.

Bharat Biotech’s vaccine Covaxin shows that it is 77.8% efficacy

The vaccine is produced with Bharat Biotech's in-house vero cell manufacturing platform that has the capacity to deliver about 300 million doses.

Sputnik V certain copes with the Indian strain, expert says

The Sputnik V vaccine remained highly effective. According to the expert, it protects 100% from severe forms of the disease and deaths.

COVID-19 dual-antibody therapies prevent emergence of drug resistance

Administration of antibody therapies bypasses the body’s slower and sometimes less effective process of making its own antibodies.

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...
spot_img

Expert Articles

spot_img